Researchers report children who received chemotherapy alone for acute lymphoblastic leukemia remain at risk for attention and learning problems after the treatment ends.
A new study provides additional insight into the cognitive losses often seen as a result of chemotherapy and in some autoimmune diseases.
Chemotherapy is often blamed for memory loss and cognitive problems in cancer survivors. However, new research published in Neuroscience challenges this belief. Researchers report cognitive impairments, often referred to as Chemo Fog, may actually start as the tumor grows and develops.
Researchers have identified the 3D structure of a brain receptor that causes vomiting and nausea as a result of chemotherapy treatments for cancer. The same receptor also plays a critical role in pain perception, migraines and chronic itching.
Many breast cancer survivors report cognitive problems following treatment. New research from UCSD finds breast cancer survivors who increase physical activity and embark on regular exercise experience improved mental processing.
A new study reports inflammation in the blood may play a role in cognitive problems following chemotherapy. Researchers report identifying the inflammatory biomarkers and reducing inflammation may prevent some of the symptoms of chemo brain.
Researchers confirm the mental fogginess produced as a result of taking the cancer drug tamoxifen, is real. They have also discovered an existing drug compound which appears to counteract the effects of this medication.
The brain’s key “breeder” cells secrete substances that boost the numbers and strength of critical brain-based immune cells believed to play a vital role in brain health. This finding adds a new dimension to our understanding of how resident stem cells and stem cell transplants may improve brain function.